Medical Science Liaison

About Oncopeptides:

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers. The company is focusing on the development of the lead product candidate melflufen, a novel peptide-drug conjugate that rapidly delivers a cytotoxic payload into tumor cells.  Melflufen is in development as a new treatment for the hematological cancer multiple myeloma and is currently being tested in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Oncopeptides’ US headquarters is based in Waltham, MA with an office in Mountain View, CA, and global headquarters is in Stockholm, Sweden. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO.


The company is in a strong financial position and has an effective Executive Team and Board of Directors. Discover more about Oncopeptides at www.oncopeptides.com



Position:  

The Medical Science Liaison (MSL) will represent Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers and their pipeline, beginning with its’ lead product candidate, the novel peptide drug conjugate, Melflufen. Melflufen is being assessed as a potential therapy for triple class refractory multiple myeloma.  Programs in amyloidosis are currently in development

The MSL, who is field based, is responsible for developing, coordinating and assuring implementation of Oncopeptides corporate, scientific, and clinical strategies in her/his loco-regional area/territory.  

The MSL will function as a subject matter expert and engage thought leaders, payers and other stakeholders specializing in the delivery of hematology and oncology therapeutics and supportive care in medical and scientific exchanges. These exchanges will be performed in a compliant fashion. Insights gathered and the information shared during these exchanges will be used to support and/or expand current clinical and scientific concepts including and related to disease state and therapeutic awareness.  Furthermore, these exchanges will inform development and business strategies.  They will also ensure the safe and effective utilization of Oncopeptides product(s).  The MSL is responsible for cultivating and maintaining collaborative relationships with influential members of her/his loco-regional medical community to enable the conduct of these scientific exchanges.  

Support of Oncopeptides research initiatives is another important role of the MSL.  MSLs will work with other members of the organization, corporate partners, and investigators to compliantly support corporate sponsored clinical trials, Real World Data generation, and investigator-sponsored studies. MSLs will also participate in and contribute to projects and initiatives that increase the value and productivity of the Medical Affairs team.

This position is field-based.  

Domestic and international travel up to 50%.

Key responsibilities include, but are not limited to:

  • Establish Oncopeptides as a leading company committed to patient access and the advancement of Melflufen and other novel peptide-drug conjugates as a treatment option for hematologic cancers.

  • Maintain clinical, scientific and technical expertise in multiple myeloma (and other relevant disease state areas).

  • Have a thorough understanding of the development process for Melflufen and other Oncopeptides products, clinical protocols and related procedures.

  • Collaborate with other members of the medical affairs, clinical development, commercial teams; serve as an Oncopeptides resource to HCPs, large group medical practices, payers and formulary decision makers.

  • Develop and track key opinion leader (KOL) engagement plans – identify, develop and maintain long-term collaborative relationships with KOLs within assigned region.

  • Participate in medical and scientific exchanges with the medical/ scientific community including advisory boards in a compliant manner

  • Provide medical/ clinical teams with feedback and insights from interactions with KOLs and investigators

  • Respond to and document unsolicited requests for information on Oncopeptides’ products and clinical programs.

  • Support internal requests for dossier review and comment, medical review/consideration of potential business development opportunities and other unique projects as requested.

  • Participate in/support the training of Oncopeptides field and home office employees.

  • Facilitate research collaborations (including REMS programs, Real World Data [RWD] generation and investigator initiated trials [IITs) with key investigators including helping identify, establish and maintain such collaborations.

  • Represent the company at medical meetings through Medical Affairs’ Scientific Booth coverage and other related activities.

  • Engage in speaker identification, training and evaluation and provide support for advisory board meetings as requested.

  • Collaborate with Market Access and Commercial colleagues for thought leader and institutional engagement where appropriate.

  • Adhere to corporate SOPs and ensure vigilant compliance with relevant legal and regulatory guidelines governing scientific interactions with physicians and healthcare professionals across all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/ scientific information.

 

Ideal Experience:

  • An advanced degree required (Pharm D, PhD or MD) preferred; advanced professional degree (e.g. NP, PA, R.Ph., MA, BSN) will be considered

  • A minimum of 2 years previous MSL or pharmaceutical industry experience (e.g. Medical Information, Medical Communications, etc.) necessary and/or a minimum of 2 years of clinical or research experience in the area of Oncology and/or immunology strongly preferred.

  • Ability to travel, locally and regionally, up to 50% with overnight stays (e.g., KOL meetings, site locations, internal meetings, medical meetings and congresses, training)

  • Experience working with payers of formulary committees strongly preferred

  • Knowledge of FDA requirements and PhRMA Code, including regulations governing compliant scientific exchange

  • Demonstrated ability to integrate and work in cross functional network/matrix

  • Demonstrated project management ability

  • Excellent communication (oral and written) and interpersonal skills

  • Valid driver’s license


Ready to Join?

 As an equal opportunity employer, Oncopeptides, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. For more information about equal employment opportunity protections, please view the ‘EEO is the Law’ poster.

 In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers AT oncopeptides.com for assistance.

 Oncopeptides, Inc. is enrolled in E-Verify® and participates in E-Verify® in addition to our Form I-9 process.  www.dhs.gov/E-Verify.

To all recruitment agencies: Oncopeptides, Inc. does not accept unsolicited agency resumes and will not be responsible for the payment of placement fees related to unsolicited resumes submitted to open positions, job aliases, or to our employees. 




#LI-NM1

Oncopeptides Inc. develops targeted therapies for difficult-to-treat hematological diseases.

Oncopeptides Inc. Company Image


Back to top